MELDUNG VOM 19.05.2017 12:20
Meldung drucken Artikel weiterleiten
pta20170519027
Public disclosure of inside information according to article 17 MAR
Pressefach Pressefach

Biofrontera AG: Biofrontera enters into finance contract with European Investmentbank

Leverkusen (pta027/19.05.2017/12:20) - Biofrontera AG (FSE: B8F), the specialist for the treatment of sun-induced skin cancer, and the European Investment Bank (EIB) have entered into an agreement today according to which the EIB will provide a loan of up to EUR 20 Million to the Biofrontera-Group. The loan is secured by a guarantee of the European Fund for Strategic Investments (EFSI). Up to EUR 10 Million will be available for disbursement from signature. Further EUR 10 Million may be drawn in two tranches within the next 24 months based on prior achievement of operational milestones. There is no obligation to call these tranches and no obligation to pay any commitment interest. Each tranche must be repaid five years after drawdown.

The Management Board

(Ende)

Aussender: Biofrontera AG
Hemmelrather Weg 201
51377 Leverkusen
Deutschland
Ansprechpartner: Investor & public relations
Tel.: +49 (0) 214 87 63 20
E-Mail:
Website: www.biofrontera.com
ISIN(s): DE0006046113 (share)
Börsen: regulated market in Dusseldorf, Frankfurt; free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate
Biofrontera AG
AKTUELLE BUSINESS NEWS
25.06.2018 13:30
Preise für Camping: Deutschland nur im Mittelfeld
pressetext.redaktion
25.06.2018 11:30
TPA erweitert und verjüngt die Eigentümerbasis deutlich
TPA Steuerberatung GmbH
25.06.2018 10:00
Arrow und next layer kooperieren in Österreich
Arrow ECS Internet Security AG
25.06.2018 06:15
Share-Economy-Angebote auf absteigendem Ast
pressetext.redaktion
23.06.2018 16:10
Online-Marketing-Ausbildung im Sommer
Online-Marketing-Forum.at
22.06.2018 12:30
Peer-to-Peer-Bezahlsysteme immer beliebter
pressetext.redaktion
Weitere News anzeigen